Suomi

Lumibird Medical nordics

Kuivat silmät

Meillä on laitteita kuivasilmäisyyden diagnostiikkaan, seurantaan sekä hoitoon.

Quantel Medical Lacrydiag
Quantel Medical Lacrydiag Logo

Valmistaja: Quantel Medical
Tuote: Lacrydiag

OCULAR SURFACE ANALYSER

Complete and quick diagnostic to identify the origin of dry eye

4 non-contact exams complying with the criteria of the TFOS – DEWS 2 report:

  • NIBUT
  • Interferometry
  • Tear meniscus heigth
  • Meibography

Additional exams: blepharitis and demodex imaging, bulbar redness, staining (corneal, conjunctiva and lid margin), pupillometry, white to white measurement, corneal deformation.

CLINICAL BENEFITS:

  • Diagnose the cause of dry eye earlier
  • Offer patients personalised and effective treatment from the first visit
  • Provide evidence of diagnosis and treatment results
  • Optimise post-surgery results (refractive, cataract)
  • Optimise the comfort of contact lens wearer
Lataa esite
Tarjouspyyntö

Valmistaja: Quantel Medical
Tuote: C.STIM

IPL SYSTEM

Treatment of the root causes of dry eye thanks to the multiple mechanisms of action of IPL: Meibomian Gland Dysfunction (MGD), inflammation (rosacea and blepharitis) and Demodex

Quick and easy treatment (<10 min)

Revolutionary IPL relying on our unique Stim-ULI™ (Uniform Light Intensity) technique, C.Stim™ offers the best combination of clinical efficacy and patient comfort. Thanks to a perfectly homogeneous distribution of energy, C.Stim™ ensures safe and effective treatment.

Treatment on the majority of skin types thanks to optimized characteristics (light spectrum, regulated pulse train, water cooling, unique Stim-ULI™ technology)

CLINICAL BENEFITS:

  • Improved tear film quality [14,15,21]
  • Better meibum quality and expression [16,17]
  • Reduction in patient symptoms [17]
  • Neuropathic pain relief [18]
  • Reduced inflammatory markers (cytokines) in tears [19,20]
Lataa esite
Tarjouspyyntö
CLINICAL REFERENCES
1. Parasympathetic Innervation of the Meibomian Glands in Rats – Mark S. LeDoux et al. – Investigative Ophthalmology & Visual Science, October 2001, Vol. 42, No. 11.
2. Characterization of the innervation of the meibomian glands in humans, rats and mice – Bründl, M. et al. Annals of Anatomy (2021), Vol. 233.
3. Neurotransmitter Influence on Human Meibomian Gland Epithelial Cells – Wendy R. Kam and David A. Sullivan – Investigative Ophthalmology & Visual Science, November 2011, Vol. 52, No. 12.
4. The Dopaminergic Neuronal System Regulates the Inflammatory Status of Mouse Lacrimal Glands in Dry Eye Disease – Ji, Yong Woo et al. Investigative Ophthalmology & Visual Science (2021), Vol. 62.
5. TFOS DEWS II Pathophysiology Report – Anthony J. Bron, et al. – The Ocular Surface, 2017, p 441 to 515.
6. The neurobiology of the meibomian glands – Cox SM, Nichols JJ – Ocular Surface, July 2014.
7. Multicenter Study of Intense Pulsed Light Therapy for Patients with Refractory Meibomian Gland Dysfunction – Reiko Arita, et al. – Cornea Volume 37, Number 12, December 2018.
8. Rosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory Condition – Yu Ri Woo, et al. International Journal of Molecular Sciences, September 2016.
9. Rosacea: Epidemiology, pathogenesis, and treatment – Barbara M. Rainer et al. – DERMATO-ENDOCRINOLOGY 2018, VOL. 9, NO. 1, e1361574 (10 pages).
10. Treatment of ocular rosacea – Edward Wladis et al. – Survey of Ophthalmology (2018), Vol. 63.
11. Improved telangiectasia and reduced recurrence rate of rosacea after treatment with 540 nm-wavelength intense pulsed light: A prospective randomized controlled trial with a 2-year follow-up – Luo,
Y. et al. – Experimental and Therapeutic Medicine (2020), Vol. 19.
12. Therapeutic Effect of Intense Pulsed Light on Ocular Demodicosis – Zhang, X., et al. – Current Eye Research 2019, Vol. 3.
13. Intense Pulsed Light Therapy for Patients with Meibomian Gland Dysfunction and Ocular Demodex Infestation – Cheng et al. – Current Medical Sciences (2019), Vol. 39.
14. Long-term effects of intense pulsed light treatment on the ocular surface in patients with rosacea-associated meibomian gland dysfunction – Seo Kyoung Yul et al. – Contact Lens and Anterior
Eye (2018), Vol. 41.
15. TFOS DEWS II Tear Film Report – Willcox Mark et al. – The Ocular Surface (2017), Vol. 15.
16. Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction – Vigo, L. et al. – Journal of Visualized Experiment (2019), N°146.
17. Meibum Expressibility Improvement as a Therapeutic Target of Intense Pulsed Light Treatment in Meibomian Gland Dysfunction and Its Association with Tear Inflammatory Cytokines – Choi,
M. et al. – Scientific Reports (2019), Vol. 9.
18. TFOS DEWS II Pain and Sensation Report – Belmonte Carlos, et al. – The Ocular Surface (2017), Vol. 15.
19. Analysis of Cytokine Levels in Tears and Clinical Correlations After Intense Pulsed Light Treating Meibomian Gland Dysfunction – LIU, R et al. – American Journal of Ophthalmology (2017).
20. Effect of inflammation on lacrimal gland function – Driss Zoukhri – Experimental Eye Research, May 2006; 82(5): 885–898.
21. Aqueous deficiency is a contributor to evaporation-related dry eye disease – Charles W. McMonnies – Eye and Vision (2020) 7:6.

Tarjouspyyntö

Haluatko tarjouksen tai lisätietoja tuotteistamme. Ota yhteyttä lomakkeen kautta, vastaamme normaalisti 24 tunnin kuluessa.

Tämän lomakkeen laatimisesta saadut tiedot saa Lumibird Medical Nordics Oy:n osastolta, joka antaa meille oikeuden vastata tässä lomakkeessa esitettyihin kysymyksiin. Esiin syntyvän tiedon käsittelyn oikeusperusta perustuu suostumukseesi. Tietoja säilytetään digitaalisesti 3 vuotta, ja niitä käytetään vain Lumibird Medical Nordics Oy:n sisällä ja tarvittaessa jälleenmyyjiemme ja/tai tytäryhtiöiden kautta. Sinulla on oikeus käyttää, oikaista, riitailla, rajoittaa tai pyytää, että poistamme nämä tiedot. Lisätietoja oikeuksistasi GDPR:n kautta on tietosuojakäytännössämme. Tai ota meihin yhteyttä info.fi@lumibirdmedicalnordics.com.

Lumibird Medical Nordics OY

Tuotealueet

Uutiskirje

Uutiskirje